Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more

Recent & Breaking News (NDAQ:NVCN)

Mid-Morning Market Update: Markets Edge Lower; Macy's Earnings Top Estimates

Benzinga.com  February 26, 2019

IIROC Trade Resumption - NVCN

Canada NewsWire February 26, 2019

Neovasc Announces Pricing of $5 Million Public Offering of Common Shares

PR Newswire February 26, 2019

IIROC Trading Halt - NVCN

Canada NewsWire February 25, 2019

Neovasc Announces Proposed Public Offering of Common Shares

PR Newswire February 25, 2019

Neovasc Announces Refiling of Interim Financial Statements and Management's Discussion and Analysis for the Period Ended September 30, 2018

Canada NewsWire February 22, 2019

Neovasc Celebrates 5-Year Anniversary of Tiara Patient as the Longest Surviving Transcatheter Mitral Valve Replacement in the World

PR Newswire February 21, 2019

Neovasc Provides Corporate Update

Canada NewsWire February 20, 2019

Pierangeli Clinic Initiates Program Providing Neovasc Reducer™ Procedure to Italian Patients with Refractory Angina

Canada NewsWire February 11, 2019

Neovasc Announces Renewal of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory Angina

Canada NewsWire January 30, 2019

Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK

Canada NewsWire January 29, 2019

Neovasc announces peer reviewed publication in JACC demonstrating objective evidence of improvement in perfusion after Reducer implantation

Canada NewsWire January 23, 2019

Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Profit Tops Expectations

Benzinga.com  January 22, 2019

Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences

Canada NewsWire January 22, 2019

Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

Canada NewsWire January 14, 2019

Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

Canada NewsWire January 3, 2019

Neovasc Receives ISO 13485: 2016 Certification

Canada NewsWire December 21, 2018

Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer™ as Published in JACC

Canada NewsWire December 11, 2018

The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved

Benzinga.com  November 29, 2018

The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings

Benzinga.com  November 20, 2018